CompletedPhase 2NCT00777738

Efficacy of Bortezomib (Velcade(R)) in Patients With Advanced Waldenström Macroglobulinemia

Studying Waldenström Macroglobulinemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Véronique LEBLOND, MD, PhD, M.D
Assistance Publique Hopitaux de Paris
Intervention
BORTEZOMIB(drug)
Enrollment
34 enrolled
Eligibility
18 years · All sexes
Timeline
2008 – 2012

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00777738 on ClinicalTrials.gov

Other trials for Waldenström Macroglobulinemia

Additional recruiting or active studies for the same condition.

See all trials for Waldenström Macroglobulinemia →

← Back to all trials